Tag: Cancer: Kidney
ASCO: Cabozantinib Improves Progression-Free Survival in RCC
Improvements seen across patient subgroups defined by risk category, tumor burden, prior therapy
FDA Approves Opdivo for Advanced Renal Cell Carcinoma
Drug works by targeting the PD-1/PD-L1 cellular pathway
Diabetes Predicts Worse Survival in Renal Cell Carcinoma
For patients with diabetes, poor glycemic control linked to higher risk of postoperative progression
Barbecued, Pan-Fried Meat May Raise Renal Cell Carcinoma Risk
High-heat cooking methods implicated in new study
Specific Genetic Alterations in Papillary Renal-Cell Carcinomas
Specific alterations seen in type 1 and type 2 carcinomas; type 2 consists of at least three subtypes
Sorafenib, Sunitinib May Pose Cardiovascular Risk
Higher stroke risk found in older kidney cancer patients taking the drugs
Novel Immunotx Shows Promise Against Advanced Renal Cancer
Nivolumab appears to outperform everolimus in new clinical trial
Surveillance Beats Radical Nephrectomy for Small Masses
Active surveillance equal to partial nephrectomy for renal function preservation
Smoking Ups Risk of Some Renal Cell Cancer Histological Subtypes
Higher risk for clear cell, papillary renal cell carcinoma, but not chromophobe histology
New Urine Biomarkers Identified for Renal Cell Carcinoma
Clinical utility, specificity, and sensitivity for urine aquaporin-1 and perilipin-2
